Home
Photonz Corporation is a biotechnology company producing the omega-3 fatty acid eicosapentaenoic acid (EPA) from marine microalgae. EPA is a critical ingredient in regulated pharmaceutical products addressing the cardiovascular disease drug market.
Pharmaceuticals using EPA as an active ingredient are experiencing high growth. Previously, EPA could only be sourced from fish oil. Our product is designed to insure manufacturers in a multi-billion dollar market against the risk of reliance on natural fisheries as their main source of EPA.
Recent News
13-Aug-2010
Dr. Douglas Wilson appointed to Board of Directors
Dr John Douglas Wilson ( MB, ChB, PhD, FRACP, FRCPA) has been appointed to the Board of Director...13-Aug-2010